GH financial statements
The full income statement, balance sheet, and cash-flow statement for Guardant Health Inc. (GH), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.
Shares outstanding (point-in-time)
SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.
| Line item | Trend | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Income Statement | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Revenue | 982M YoY+32.9% | 739M YoY+31.0% | 564M YoY+25.5% | 450M YoY+20.3% | 374M YoY+30.3% | |
| Cost of revenue | 349M YoY+20.4% | 290M YoY+27.6% | 227M | — | — | |
| Research & development | 364M YoY+4.7% | 348M YoY-5.3% | 367M YoY-1.8% | 374M YoY+42.0% | 263M YoY+75.6% | |
| Selling, general & administrative | 211M YoY+17.4% | 180M YoY+15.6% | 156M YoY-5.0% | 164M YoY-20.7% | 207M YoY+7.2% | |
| General & administrative | 211M YoY+17.4% | 180M YoY+15.6% | 156M YoY-5.0% | 164M YoY-20.7% | 207M YoY+7.2% | |
| Selling & marketing | 495M YoY+35.5% | 365M YoY+23.6% | 295M YoY-1.5% | 300M YoY+56.3% | 192M YoY+80.1% | |
| Amortization of intangibles | 1.70M YoY-22.7% | 2.20M YoY-18.5% | 2.70M YoY+8.0% | 2.50M YoY+31.6% | 1.90M YoY+5.6% | |
| Operating income | -437M YoY+1.4% | -444M YoY+21.4% | -565M YoY-3.7% | -544M YoY-32.5% | -411M YoY-61.2% | |
| Interest expense | 3.90M YoY+51.0% | 2.58M YoY+0.1% | 2.58M YoY+0.0% | 2.58M YoY+0.0% | 2.58M YoY-45.9% | |
| Interest & investment income | 34.1M YoY-36.5% | 53.7M YoY+51.8% | 35.4M YoY+482.7% | 6.07M YoY+54.4% | 3.93M YoY-61.4% | |
| Other non-operating income | -10.5M YoY+75.4% | -42.6M YoY-180.1% | 53.2M YoY+516.1% | -12.8M YoY-150.8% | 25.2M YoY+591.5% | |
| Gain (loss) on equity securities | 0.00 YoY+100.0% | -44.4M YoY-155.7% | 79.7M YoY+1122.8% | -7.79M | 0.00 | |
| Pre-tax income | -418M YoY+4.0% | -435M YoY+9.1% | -479M YoY+26.7% | -653M YoY-70.0% | -384M YoY-56.3% | |
| Income tax | -1.26M YoY-198.4% | 1.28M YoY+87.4% | 685K YoY-39.9% | 1.14M YoY+279.7% | 300K YoY-20.8% | |
-416M YoY+4.6% | -436M YoY+9.0% | -479M YoY+26.8% | -655M YoY-70.1% | -385M YoY-56.2% | ||
-$3.32 YoY+6.7% | -$3.56 YoY+16.8% | -$4.28 YoY+33.2% | -$6.41 YoY-60.3% | -$4.00 YoY-53.8% | ||
| Balance Sheet | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
1.47B YoY+38.9% | 1.06B YoY-21.7% | 1.35B YoY+13.1% | 1.19B YoY+7.0% | 1.11B YoY-41.0% | ||
2.01B YoY+35.5% | 1.49B YoY-16.8% | 1.79B YoY+11.0% | 1.61B YoY-27.0% | 2.20B YoY-3.0% | ||
303M YoY+34.2% | 226M YoY+9.6% | 206M YoY+6.6% | 193M YoY-0.8% | 195M YoY+191.4% | ||
2.11B YoY+30.0% | 1.63B YoY-0.2% | 1.63B YoY+5.0% | 1.55B YoY-0.6% | 1.56B YoY+70.2% | ||
-99.3M YoY+28.9% | -140M YoY-188.0% | 159M YoY+163.7% | 60.2M YoY-90.7% | 645M YoY-50.3% | ||
| Cash Flow | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
-185M YoY+23.0% | -240M YoY+26.2% | -325M YoY-5.0% | -309M YoY-48.1% | -209M YoY-101.1% | ||
-627M YoY-140.0% | -261M YoY-131.1% | 840M YoY+460.9% | 150M YoY+337.2% | -63.2M YoY+89.8% | ||
671M YoY+67482.8% | -996K YoY-100.2% | 477M YoY+352.5% | -189M YoY-183.0% | -66.8M YoY-104.7% | ||
| Net change in cash | -140M YoY+72.2% | -504M YoY-150.8% | 992M YoY+383.1% | -350M YoY-2.8% | -341M YoY-149.4% | |
| Interest paid | 3.77M | 0.00 | 0.00 | — | 0.00 | |
| Income taxes paid | 869K YoY-13.7% | 1.01M YoY-48.9% | 1.97M YoY+47.9% | 1.33M YoY+238.7% | 393K YoY+18.7% | |
| Valuation Ratios | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Market cap | 13.4B YoY+255.3% | 3.77B YoY+18.1% | 3.19B YoY+14.6% | 2.79B YoY-72.7% | 10.2B YoY-21.3% | |
| P/S | 13.6× YoY+167.4% | 5.1× YoY-14.4% | 6.0× YoY-7.9% | 6.5× YoY-76.3% | 27.3× YoY-39.6% | |
| P/B | — | — | 14.0× YoY-16.3% | 16.7× YoY+5.8% | 15.8× YoY+58.5% | |
| Source filing | 10-K | 10-K | 10-K | 10-K | 10-K |
About this data
Source: GH's SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn't file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all GH filings on SEC EDGAR → Not investment advice.
